China-based biotech firm Therorna Inc has secured over 280 million yuan (almost $42 million) in a Series A round. Separately, HR tech firm Shebao China has completed a Series C funding round at 270 million yuan ($40.4 million) alongside its rebranding as Yunsheng Group.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
